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The type 2 deiodinase (D2) converts the pro-hormone T4 to the metabolically active molecule 
T3, but its global inactivation (GLOB-D2KO) unexpectedly lowers the respiratory exchange rate 
(RQ) and increases food intake. Here we used FloxD2 mice to generate systemically euthyroid 
FAT-specific (Fabp4-Cre), ASTROCYTE-specific (GFAP-Cre) or SKELETAL MUSCLE-
specific (MLC-Cre) D2KO mice that were monitored continuously. The ASTRO-D2KO mice 
also exhibited lower diurnal RQ and greater contribution of fatty acid oxidation to EE, but no 
differences in food intake were observed. In contrast, the FAT-D2KO mouse exhibited sustained 
(24 h) increase in RQ values, increased food intake, tolerance to glucose and sensitivity to insu-
lin, all supporting greater contribution of carbohydrate oxidation to EE. Furthermore, FAT-
D2KO animals that were kept on a high-fat diet for 8 weeks gained more body weight and fat, 
indicating impaired brown adipose tissue (BAT) thermogenesis and/or inability to oxidize the fat 
excess. Acclimatization of FAT-D2KO mice at thermoneutrality dissipated both features of this 
phenotype. Muscle D2 does not seem to play a significant metabolic role given that SKM-D2KO 
animals exhibited no phenotype. The present findings are unique in that they were obtained in 
systemically euthyroid animals, revealing that brain D2 plays a dominant albeit indirect role in 
fatty acid oxidation via its sympathetic control of BAT activity. D2-generated T3 in BAT accel-
erates fatty acid oxidation and protects against diet-induced obesity.  
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Introduction 
 
Thyroid hormone signaling is initiated by entry of 3,5,3’-triiodothyronine (T3) into target cells 
and binding with nuclear T3-receptors (TR), modulating the expression of T3-responsive genes 
(1). Signaling through this pathway is also affected by local events, with target cells playing a 
role through controlled expression of the activating or inactivating deiodinases (2). These en-
zymes are thyroredoxin fold-containing selenoproteins that can activate the pro-hormone 
thyroxine (T4) to its active form T3 (type II deiodinase: D2) or inactivate both T4 and T3, and 
T3 to T2 (type III deiodinase: D3) (3-5). As a result, cells that express D2 have higher T3 levels 
and thus exhibit an enhanced T3-dependent mRNA footprint, and the opposite is observed in D3-
expressing cells. Thus, customizing thyroid hormone signaling via deiodinases is an important 
mechanism in energy homeostasis (2), brain (6), brown adipose tissue (BAT) (7), pancreatic β-
cell (8), heart (9) and skeletal muscle (10, 11).  
 
Inactivation of the D2 gene (Dio2) affects the expression of T3-dependent genes in D2-
expressing tissues such as BAT and brain, essentially dampening thyroid hormone signaling in a 
tissue-specific fashion (12). Accordingly, a mouse with global inactivation of the Dio2 gene 
(GLOB-D2KO) exhibits a significant metabolic phenotype characterized by decreased RQ, re-
sistance to diet-induced obesity and super tolerance to glucose, some of which is reversed upon 
acclimatization at thermoneutrality (13). A similar phenomenon was observed in the UCP1-KO 
mouse (14) and in systemically hypothyroid mice (15). These findings indicate that an increase 
in sympathetic activity at room temperature plays a role in defining the metabolic phenotype of 
animal models exhibiting a disruption in thyroid hormone signaling, either localized (GLOB-
D2KO) or systemic (16, 17).  
 
D2-generated T3 has been shown to play a critical role in BAT UCP-1 expression (18, 19) and 
BAT thermogenesis (20). Thus, the metabolic phenotype displayed by the GLOB-D2KO mouse 
has been largely attributed to the lack of D2-generated T3 in BAT (13, 21, 22). In fact, BAT D2 
is induced by sympathetic activity and rapidly increases thyroid hormone signaling during cold 
exposure (23, 24). However, a number of other metabolically relevant tissues in the rodent ex-
press D2, e.g. brain (25), skeletal muscle (26), bone (27), and could also play a role in defining 
the metabolic phenotype of the GLOB-D2KO mouse. For example, D2 is expressed in the 
mediobasal hypothalamus (28, 29) where it has been implicated in the orexigenic response dur-
ing re-feeding (30) and in lowering TRH/TSH secretion in disease states (31). At this time, it is 
still not clear what, if any, metabolic roles D2 plays in skeletal muscle and bone.  
 
The lower RQ observed in the GLOB-D2KO animals is unexpected because thyroid hormone 
administration is known for accelerating fatty acid oxidation (32) and lowering RQ values (33). 
However, given that the lower RQ values are dissipated once the GLOB-D2KO animals are ac-
climatized to thermoneutrality (13), it is likely that a compensatory increase in BAT sympathetic 
activity plays a role (16, 17). Of note, a subsequent study did not find a lower RQ in the GLOB-
D2KO mouse studied briefly by indirect calorimetry (34), despite reduced liver glycogen and 
elevated serum βOH-butyrate levels, which is commonly associated with increased sympathetic 
activity and fatty acid oxidation (35). 
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The present studies were performed to define the mechanism(s) and anatomical site(s) whereby 
D2-mediate T3 production affects fatty acid oxidation as reflected in the RQ. To this aim, we 
compared the metabolic phenotype of the GLOB-D2KO mouse with that of three other systemi-
cally euthyroid mouse strains that exhibit (i) astrocyte-specific (ASTRO-D2KO), (ii) fat-specific 
(FAT-D2KO) or (iii) skeletal muscle-specific (SKM-D2KO) inactivation of Dio2 after they were 
admitted to a comprehensive lab animal monitoring system (CLAMS) and monitored continu-
ously through indirect calorimetry. Our findings indicate that brain D2 indirectly inhibits BAT 
fatty acid oxidation via dampening of sympathetic activity in BAT. In contrast, D2-generated T3 
in BAT accelerates fatty acid oxidation given that selective disruption of this pathway in BAT 
increases RQ and predisposes to diet-induced obesity. No significant metabolic phenotype result-
ing from D2 inactivation in skeletal muscle was identified. The evidence obtained through the 
use of these animal models is unique in its physiological relevance because it reflects the result 
of tissue-specific D2 inactivation in an otherwise systemically euthyroid animal. 
 
 
 
5 
 
Material and Methods 
 
Animals 
All experimental procedures were planned following the American Thyroid Association guide to 
investigating thyroid hormone economy and action in rodent and cell models (36), and approved 
by the local Institutional Animal Care and Use Committee. For the studies including the GLOB-
D2KO mouse, approximately 10 weeks old C57BL/6J and GLOB-D2KO mice that had been 
backcrossed in the same background (22) were used from our established colonies, kept at room 
temperature (22°C), with a 12-h dark/light cycle starting at 06:00 h and housed standard plastic 
cages with four male mice per cage.  
 
For the tissue specific deletion of dio2 in adipose tissue, astrocytes and skeletal muscle cells, we 
establish an in vivo mouse model for cell-type specific deletion of D2 generating floxed D2 
(dio2Flx) mice as described (37). The dio2flx mice were crossed with transgenic mice expressing 
Cre-recombinase under the fatty acid binding protein 4 promoter (Cre-FABP4) [B6.Cg-
Tg(Fabp4-cre)1Rev/J; Jackson Laboratories, Bar Harbor ME] (38) or glial fibrillary acidic pro-
tein promoter (Cre-GFAP) [FVB-Tg(GFAP-cre)25Mes/J; Jackson Laboratories] (39) or myosin 
light chain 1f (Cre-MLC) (40). This strategy was used in order to eliminate D2 activity in the 
Fabp4- expressing adipocytes (FAT-D2KO mice), GFAP-expressing astrocytes (ASTRO-D2KO 
mice) and MLC-expressing myocytes (SKM-D2KO). In all experiments only Cre littermates 
were used as controls. The generation of the Astro-D2KO mice was recently described (37). At 
the time of the studies all mice were between 9 and 14 weeks of age.  
 
Only male animals were used. Animals were kept on standard chow diet (3.1kcal/g) (2918 
Teklan Global Protein rodent diet, Madison, WI) or a high fat diet (4.5kcal/g) (TD 95121; Harlan 
Teklad, Indianapolis, IN) as indicated. In the experiments involving the high fat feeding three 
month-old littermate controls and FAT-D2KO or SKM-D2KO mice (6 per group) that had been 
fed chow diet were switched to a high fat diet for 8 weeks, kept at room temperature (22°C) or 
thermoneutrality (30°C) as indicated. 
 
At the end of experimental period the animals were euthanized by asphyxiation in a CO2 cham-
ber. Blood was collected and serum levels of TSH, T4 and T3 measured using a MILLIPLEXTM 
rat thyroid hormone panel kit following the instructions of the manufacturer (Millipore Corpora-
tion, Billerica MA) and read on a BioPlex (BioRad, Hercules CA).  
 
Body composition 
Lean body mass (LBM) and fat mass were determined by dual energy x-ray absorptiometry 
(DEXA; Lunar Pixi, Janesville, WI) as described previously (13).  
 
Indirect calorimetry 
Animals were admitted to a comprehensive lab animal monitoring system (CLAMS - OXYMAX 
System 4.93 - Columbus Instruments, Columbus, OH) (13) with free access to food and water. 
Studies were performed at 22°C, 18°C, 15°C, 11°C and 5°C for the indicated times. Animals 
were allowed to acclimatize in individual metabolic cages for 48 h before any measurements. 
Subsequently, metabolic profiles were generated as indicated and the data collected in the next 
36 h. This system allows for continuous measurement of Oxygen consumption (VO2; ml/kg 
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BW/h) and carbon dioxide production (VCO2) in successive 14 or 26-min cycles, using a sensor 
calibrated against a standard gas mix containing defined quantities of O2 and CO2. These data 
were used to calculate the respiratory exchange ratio (RQ) (VCO2/VO2) and the Energy Expendi-
ture (EE) ([3.815+1.232●RQ]●VO2). Contribution of fat acid oxidation to energy expenditure 
(EE) was calculated as described using the following equation: % fat contribution = (468.6●(1-
RQ))/(5.047●(RQ-0.707)+4.686●(1-RQ) (41). 24 h caloric intake was measured at the indicated 
times while the animals were admitted to the CLAMS. 
 
Glucose and insulin tolerance tests 
For glucose tolerance tests, mice were fasted overnight and the glucose measurement was made 
as described previously (42). For insulin tolerance tests, mice with food ad libitum were injected 
with insulin and the glucose measurement was made as described previously (42). 
 
Deiodinase assays 
D2 activity assay was performed in BAT sonicates as described previously (43, 44).  
 
Statistical analysis 
All data are expressed as mean ± SEM and were analyzed using PRISM software (GraphPad 
Software, San Diego, CA). One-way ANOVA was used to compare more than two groups, fol-
lowed by the Student-Newman-Keuls test to detect differences between groups. The Student’s t 
test was used only when two groups were part of the experiment. P<0.05 was used to reject the 
null hypothesis. 
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Results 
 
GLOB-D2KO mice exhibit increased diurnal fatty acid oxidation  
 
Under the mild thermal stress conditions of room temperature (22˚C), all animals exhibited the 
expected circadian rhythmicity in VO2 and EE with higher values observed nocturnally, when 
animals are awake and eating, as opposed to the day-hours, when the animals are resting and 
eating much less (Fig. 1A; supplemental Fig. 1A). In this setting, no differences were observed 
between GLOB-D2KO and WT animals (Fig. 1A). The RQ profile also exhibited circadian 
rhythmicity with lower values observed diurnally (Fig. 1B). Notably, the diurnal decrease in RQ 
values was more pronounced in the GLOB-D2KO animals (Fig. 1B), resulting in greater contri-
bution of fatty acid oxidation to the diurnal EE (~50% vs. ~35 %; Fig. 1C). This diurnal drop in 
RQ was associated with a ~50 % reduction in diurnal food intake in the global-D2KO animals, 
with no differences observed nocturnally (Fig. 1D).  
 
The association between reduced food intake and increased fatty acid oxidation in the GLOB-
D2KO animals suggest an involvement of the central nervous system, presumably the hypothal-
amus. Thus, we next tested whether the differences between GLOB-D2KO and WT animals 
would be dissipated in the setting of intense hypothalamic-driven fatty acid mobilization and 
oxidation, i.e. cold exposure. Housing for 24 h at 4°C resulted in dramatic increase in VO2 and 
EE in all animals that blurred circadian rhythmicity, similar in GLOB-D2KO and WT controls 
(Fig. 1E; supplemental Fig. 1B). In contrast, the RQ profile exhibited the expected circadian 
rhythmicity in both groups of animals but the diurnal RQ difference between GLOB-D2KO and 
WT controls was dissipated (Fig. 1F). This equalized the contribution of fatty acid oxidation to 
diurnal EE (Fig. 1C). In this setting, both diurnal and nocturnal food intake were similar in all 
animals (Fig. 1G). Similar findings were obtained when the environment temperature was gradu-
ally and progressively decreased every 3 days while the animals remained in the CLAMS for a 2-
week period, except that in this case the VO2 circadian rhythmicity was preserved throughout the 
experiment (Fig. 1H-I). 
 
Decreasing BAT’s contribution to metabolism by acclimatization to thermoneutrality normalized 
the RQ in the GLOB-D2KO mouse (13). Thus, in the next set of experiments we used an alterna-
tive strategy to decrease BAT’s contribution to metabolism, i.e. fasting. In fact, a 48 h fasting 
dramatically reduced VO2 and EE while it minimized their circadian rhythmicity (Fig. 1J; sup-
plemental Fig. 1C). Furthermore, fasted GLOB-D2KO and WT controls markedly lowered their 
RQ values, and the 24-profile lost circadian rhythmicity (Fig. 1K). These changes in RQ elevated 
the contribution of fatty acid oxidation to diurnal EE to almost 80 % in all animals (Fig. 1C). 
More importantly, such as with cold exposure, fasting also dissipated the diurnal differences in 
RQ between GLOB-D2KO animals and WT controls (Fig. 1K). 
 
Astro-D2KO mice partially recapitulate the metabolic phenotype of the GLOB-D2KO animals 
 
It has been proposed that D2-generated T3 in glial cells near the arcuate nucleus play an 
orexigenic role in mice (45, 46). Thus, to test whether the lower diurnal RQ observed in GLOB-
D2KO mouse is caused by D2 inactivation in the brain we studied the ASTRO-D2KO mouse 
that lacks D2 activity in the glia but preserves D2 expression in other tissues/cells including the 
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ependimal tanycytes (37). These animals have normal serum levels of T4, T3 and TSH and are 
considered systemically euthyroid (37). The ASTRO-D2KO animals exhibit a normal growth 
curve (Fig. 2A) and during adulthood have similar body weight (Fig. 2B) and body composition 
(Fig. 2C) as compared to WT littermate controls. The CLAMS studies revealed that ASTRO-
D2KO animals have a VO2 and EE profiles that was unremarkable (Fig. 2D; supplemental Fig. 
1D), but a RQ profile that resembled that of the GLOB-D2KO mouse, i.e. lower diurnal values 
(Fig. 2E), with greater contribution of fatty acid oxidation to the diurnal EE (Fig. 2F); food in-
take however was not different when compared to WT littermate controls (Fig. 2G).  
 
Fat-D2KO mice exhibit around-the-clock reduction in fatty acid oxidation 
 
D2 is expressed in BAT and D2-generated T3 has been shown to regulate local fatty acid synthe-
sis (16, 47, 48). To test whether D2-generated T3 in BAT affects fatty acid oxidation we next 
studied FAT-D2KO mice that lack BAT D2 expression (supplemental Fig. 2A) and activity 
(supplemental Fig. 2B) while expressing D2 normally in other tissues (supplemental Fig. 2C). 
These animals have no gross abnormalities, develop and grow normally up until age 5 months, 
when they exhibit a slightly reduced rate of weight gain (Fig. 3A). These animals also exhibit 
normal serum levels of T4, T3 and TSH (supplemental Fig. 2D-F) and are considered systemical-
ly euthyroid. 
 
Adult FAT-D2KO mice exhibit similar body weight (Fig. 3B) and body composition (Fig. 3C) 
when compared to littermate controls. Their VO2 and EE profiles showed no differences when 
compared to littermate controls (Fig. 3D; supplemental Fig. 1E). However, RQ values were sub-
stantially higher in the FAT-D2KO mice across the 24 h cycle (Fig. 3E), indicating that the ab-
sence of D2 in BAT (and WAT) reduces the contribution of fatty acid oxidation to EE (Fig. 3F). 
It is notable that FAT-D2KO animals also exhibit greater food intake throughout the 24 h cycle 
(Fig. 3G), although their body weight (Fig. 3B) and body composition (Fig. 3C) are not different 
from WT littermate controls. The relatively greater contribution of glucose oxidation to EE was 
further documented through IPGTT and ITT (Fig. 3H-I). FAT-D2KO animals were more tolerant 
to glucose (Fig. 3H) and exhibited a greater sensitivity to insulin administration (Fig. 3I) when 
compared to WT littermate controls. 
 
Given that D2 activity in WAT is minimal, these differences in RQ are likely to reflect the ab-
sence of D2 in BAT. To test if this was the case, we used similar strategy as with the GLOB-
D2KO animals, i.e. to minimize BAT contribution to EE by acclimatization at thermoneutrality 
(30˚C for 8 weeks) or by fasting. Acclimatization at thermoneutrality resulted in significant re-
duction in VO2 and EE, with no differences between FAT-D2KO and control animals (Fig. 3J; 
supplemental Fig. 1F). Notably, in this setting the RQ values for the FAT-D2KO decreased and 
became indistinguishable from WT littermate controls (Fig. 3K), with similar observations for 
food intake (Fig. 3L). At the same time, fasting dramatically reduced VO2 and EE as well as their 
circadian rhythmicity (Fig. 3M-N; supplemental Fig. 1G). More importantly, fasting also dissi-
pated the differences in RQ between FAT-D2KO and WT littermate controls (Fig. 3N). 
 
FAT-D2KO mice are more susceptible to diet-induced obesity 
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Given the relative reduction in fatty acid oxidation in the FAT-D2KO BAT, we hypothesized 
these animals would have impaired BAT thermogenesis and therefore be more susceptible to 
diet-induced obesity. To test if this was the case, FAT-D2KO animals were placed on a HFD for 
8 weeks and notably gained significantly more body weight than WT littermate controls (Fig. 
4A-B) while exhibiting similar food consumption (Fig. 4C).  In addition, at the end of the exper-
imental period the FAT-D2KO animals had experienced a greater increase in body fat than WT 
littermate controls kept on the same diet (Fig. 4D-E), but the contribution of fatty acid oxidation 
to EE remained unaffected (Fig. 4F) and the VO2, EE and RQ profiles were not different in these 
animals (Fig. 4G-H; supplemental Fig. 1H). Next, to confirm that the greater gain in body weight 
and body fat in the FAT-D2KO animals were due to impaired BAT thermogenesis, we repeated 
the HFD for 8 weeks while the animals were kept continuously at thermoneutrality. While food 
intake remained largely unaffected (Fig. 4K),both groups of animals gained body weight (Fig. 
4I-J) and body fat (Fig. 4L-M) in the same proportion once BAT’s contribution to EE was mini-
mized. Furthermore, CLAMS studies indicated that VO2, EE and RQ profiles as well as fatty acid 
contribution to EE were indistinguishable between both groups of animals (Fig. 4N-P; supple-
mental Fig. 1I). 
 
SKM-D2KO mice have neutral metabolic phenotype 
 
Skeletal muscle expresses low levels of D2 activity but its relatively large mass suggests that D2-
generated T3 in this organ may contribute significantly to the overall metabolism. We tested if 
this was the case by using a mouse model that lacks D2 in the skeletal muscle but preserves D2 
activity in all other tissues, i.e. the SKM-D2KO mouse (49). These animals have normal serum 
levels of T4, T3 and TSH and are considered systemically euthyroid (49). SKM-D2KO mice 
exhibit a similar growth curve as littermate controls (Fig. 5A) and, during adulthood, also exhibit 
similar body weight (Fig. 5B) and body composition (Fig. 5C). The VO2 (Fig. 5D), EE (supple-
mental Fig. 1J) and RQ profiles (Fig. 5E) as well as the contribution of fatty acid oxidation to EE 
(Fig. 5F) showed no differences when compared to WT littermate controls; food intake was also 
similar between groups (Fig. 5G). Next, SKM-D2KO animals were placed on a HFD for 8 weeks 
to test their ability to handle an excess of calories. Remarkably, these animals exhibited similar 
gain of body weight (Fig. 5H-I) and fat (Fig. 5J-K) as compared to WT littermate controls, with 
no differences observed in the VO2 (Fig. 5L), EE (supplemental Fig. 1L) and RQ (Fig. 5M) pro-
files. 
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Discussion 
 
The utilization of systemically hypothyroid or hyperthyroid animals has been the traditional ap-
proach to study thyroid hormone action (36). However, almost all tissues and cells respond to 
thyroid hormone and set off waves of secondary and tertiary effects that are not directly regulat-
ed by thyroid hormone. Furthermore, that thyroid hormone membrane transporters, deiodinases 
and TR subtypes can customize thyroid hormone effects on target tissues makes the systemic 
approach unsuitable for the study of cell-specific thyroid hormone actions. The present studies 
employed a series of systemically euthyroid animal models that exhibit tissue-specific disruption 
of the D2 pathway and identified a multi-level physiological control of fatty acid oxidation by 
thyroid hormone. The present findings are unique in that the animal models used remained sys-
temically euthyroid throughout the experiments, revealing the physiological multi-level roles 
played by D2-generated T3 in fatty acid oxidation.  
 
Selective inactivation of the D2 pathway in glial cells (ASTRO-D2KO) accelerates the diurnal 
rate of fatty acid oxidation in the BAT (Fig. 2E). These findings are in line with the concept that 
localized thyroid hormone signaling in the hypothalamus and other brain areas (e.g. brain stem) 
regulate appetite, BAT sympathetic activity (50, 51) and downstream metabolic and cardiovascu-
lar targets (52). In contrast, inactivation of D2 in a peripheral tissue, i.e. BAT (FAT-D2KO), led 
to the opposite metabolic phenotype, including a slower rate of fatty acid oxidation (Fig. 3E) and 
increased the contribution of carbohydrate oxidation to the overall EE (Fig. 3F). FAT-D2KO 
mice were also susceptible to diet-induced obesity and gained more weight and body fat on a 
HFD (Fig. 4C-D). Notably, disruption of the D2 pathway in a second peripheral tissue, i.e. skele-
tal muscle, was metabolically neutral (Fig. 5A-I), an indication that D2 activity in this tissue is 
unlikely to play any significant metabolic role.  
 
The RQ reflects the relative contribution of fatty acid, glucose and protein oxidation to daily en-
ergy expenditure. Given that VO2 (Fig. 1A) and total daily EE (supplemental Fig. 1A) remained 
stable in the GLOB-D2KO animals, the lower diurnal RQ values (Fig. 1B) indicate an accelera-
tion of fatty acid oxidation (Fig. 1C). Liver, heart, skeletal muscle and BAT all exhibit high rates 
of fatty acid oxidation and could play a role in this process (53). That the difference in RQ is 
dissipated by BAT inactivation, i.e. thermoneutrality (13) or fasting (Fig. 1J-K), identifies BAT 
as the most likely tissue underlying this phenotype. However, is D2-generated T3 playing a di-
rect role in BAT by controlling local fatty acid oxidation or playing an indirect role in BAT via 
the central nervous system and sympathetic activity, or both?  
 
The fact that a diurnal reduction in food intake is part of this phenotype (Fig. 1D) suggests an 
involvement of the central nervous system. In addition, the fact that the difference in RQ is diur-
nal and not across the 24 h cycle does not support a “defect” in BAT but rather an adjustment 
made by the sympathetic nervous system with the possible involvement of higher control areas in 
the brain. Accordingly, maximal sympathetic stimulation of BAT during cold exposure also dis-
sipated the differences in RQ between GLOB-D2KO and WT controls (Fig. 1F,I). 
 
That the mechanism leading to lower RQ values in the GLOB-D2KO mouse is centrally mediat-
ed is supported by the previous observation that BAT norepinephrine turnover is accelerated in 
GLOB-D2KO mice maintained at room temperature (22). For example, it has been proposed that 
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D2-generated T3 in the glial cells surrounding the arcuate nucleus is important for the orexigenic 
response during fasting, by increasing appetite and decreasing BAT activity in order to preserve 
energy (30). It is conceivable that a similar mechanism in the hypothalamus or another brain area 
is taking place as illustrated with the ASTRO-D2KO mouse that lacks D2 in glial cells. Notably, 
the disruption of the glia D2 pathway partially recapitulated the phenotype of the GLOB-D2KO 
mouse, including a lower diurnal RQ (Fig. 2C-E) but not a reduced food intake (Fig. F). 
 
As it becomes apparent that D2 plays an important metabolic role in multiple tissues, the devel-
opment of the FAT-D2KO allowed for a unique insight into the direct role played by D2-
generated T3 in BAT physiology. The findings of increased RQ values in these animals indicate 
a relative state of BAT hypothyroidism despite normal serum T3 levels and provide clear evi-
dence that D2-generated T3 in BAT accelerates fatty acid oxidation. Notably, T3 accelerates 
fatty acid oxidation by stimulating the expression of rate-limiting elements in this process (32, 
54, 55), lowering RQ values (33). However, these experiments frequently involve systemically 
hypothyroid animals treated with large doses of T3. The evidence obtained in the present study is 
unique in its physiological context, reflecting the result of D2 inactivation in BAT cells in an 
otherwise systemically euthyroid animal. Only through this strategy the physiological role played 
by D2-generated T3 inside BAT cells could be appreciated.  
 
The faster clearance of glucose from the circulation and the increased insulin sensitivity (Fig. H-
I) suggest that an increased oxidation of glucose compensates for the impaired fatty acid oxida-
tion in BAT. Whereas this seems to provide sufficient compensation under standard conditions, 
placing the FAT-D2KO animals on a HFD revealed greater susceptibility to diet-induced obesity 
(Fig. 4A-D), suggestive of impaired adaptive thermogenesis. This is supported by the observa-
tion that at thermoneutrality this phenotype was neutralized (Fig. 4I-L), indicating that the sym-
pathetic nervous system and BAT play an underlying role in this process. 
 
Skeletal muscle expresses very low levels of D2, about two orders of magnitude lower than BAT 
(26, 56). However, given its large size it is conceivable that D2 contributes significantly to me-
tabolism, similarly to the D2-generated T3 in BAT. The present studies demonstrate that D2 in-
activation in skeletal muscle is metabolically neutral, not affecting any of the parameters ana-
lyzed, including VO2 and RQ, body weight and composition. In addition, we also increased the 
metabolic demand by placing these animals on a HFD and their susceptibility to diet-induced 
obesity was not affect by disruption of D2 activity in skeletal muscle (Fig. 5F-I). Thus, D2-
generated T3 in skeletal muscle is not sufficient to play any significant metabolic role.  
 
The analysis of the multiple metabolic parameters and the subsequent adjustments that follow 
disruption of the D2 pathway - under adverse conditions of environmental temperature and calor-
ic intake - prompt us to speculate what the physiological imperative is, around which all other 
parameters adjust to. In the present studies, VO2 and EE remained stable in all animal models of 
global or tissue-specific disruption of the D2-generated T3 mechanism. The present data, and 
also previously published studies, indicate that localized disruption in thyroid hormone signaling 
is well neutralized by adjustments in the sympathetic activity while maintaining a stable rate of 
EE and thermogenesis. Even in systemically hypothyroid mice, an increase in sympathetic activi-
ty neutralizes much of the expected metabolic phenotype (57). Thus, given the relatively high 
surface to volume ratio in mice, EE and thermoregulation seem to be key physiological impera-
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tives determining the direction and intensity of the adjustments observed in the present investiga-
tion.  
 
D2 is expressed in the human brain, including the hypothalamus (58), as well as BAT that is pre-
sent in adult individuals (53, 59, 60). This indicates that the present findings are potentially ap-
plicable to humans. In fact, a common Dio2 gene polymorphisms has been associated with a 
number of metabolic conditions, including increased BMI and resistance to insulin (53), support-
ing the idea that D2 could play a role regulating fatty acid utilization in humans.  
  
In conclusion, the present studies deconstructed the metabolic phenotype exhibited by a mouse 
with global inactivation of D2, explaining the unexpectedly finding of diurnal acceleration of 
fatty acid oxidation. The findings in the ASTRO-D2KO mouse indicate that D2-generated T3 in 
the brain plays a dominant albeit indirect role inhibiting BAT activity and thus slowing down 
fatty acid oxidation. The findings in the FAT-D2KO mouse, on the contrary, indicate that D2-
generated T3 in BAT accelerate fatty acid oxidation, a mechanism that when absent is partially 
compensated for by an increase in glucose utilization. However, the FAT-D2KO mouse remains 
susceptible to diet-induce obesity, illustrating how critical this mechanism is. In contrast, the D2 
pathway in skeletal muscle is unlikely to play any significant metabolic role. The metabolic 
characterization of these animal models provides a unique insight into how deiodinase-mediated 
thyroid hormone signaling is critical for energy homeostasis.  
 
 
Acknowledgment 
  
TF, JW and MC conducted experiments, data analyzes, manuscript preparation; BB, GF, EM, 
DI, CM and AF conducted experiments, data analyzes; BG created the Flox-D2 mouse, reviewed 
manuscript; A. B. data analyzes, manuscript preparation. The authors are grateful to Professor 
Carlos Moraes for kindly providing the Cre-MLC mouse used in this study. This work was sup-
ported by NIDDK R01 65055 and the European Community’s Seventh Framework Program 
(FP7/2007–2013, no. 259772).  
 
Disclosure statement  
 
The authors declare no conflict of interest.  
 
Bibliography 
 
1. Brent, G.A. 2012. Mechanisms of thyroid hormone action. J Clin Invest 122:3035-3043. 
2. Gereben, B., Zeold, A., Dentice, M., Salvatore, D., and Bianco, A.C. 2008. Activation and 
inactivation of thyroid hormone by deiodinases: local action with general consequences. Cell 
Mol Life Sci 65:570-590. 
3. Callebaut, I., Curcio-Morelli, C., Mornon, J.P., Gereben, B., Buettner, C., Huang, S., Castro, B., 
Fonseca, T.L., Harney, J.W., Larsen, P.R., et al. 2003. The iodothyronine selenodeiodinases are 
thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure. J Biol 
Chem 278:36887-36896. 
13 
 
4. Bianco, A.C., Salvatore, D., Gereben, B., Berry, M.J., and Larsen, P.R. 2002. Biochemistry, cellular 
and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr 
Rev 23:38-89. 
5. Hernandez, A., and St Germain, D.L. 2003. Thyroid hormone deiodinases: physiology and clinical 
disorders. Curr Opin Pediatr 15:416-420. 
6. Lechan, R.M. 1987. Neuroendocrinology of pituitary hormone regulation. Endocrinol Metab Clin 
North Am 16:475-501. 
7. Hall, J.A., Ribich, S., Christoffolete, M.A., Simovic, G., Correa-Medina, M., Patti, M.E., and Bianco, 
A.C. 2010. Absence of thyroid hormone activation during development underlies a permanent 
defect in adaptive thermogenesis. Endocrinology 151:4573-4582. 
8. Medina, M.C., Molina, J., Gadea, Y., Fachado, A., Murillo, M., Simovic, G., Pileggi, A., Hernandez, 
A., Edlund, H., and Bianco, A.C. 2011. The Thyroid Hormone-Inactivating Type III Deiodinase Is 
Expressed in Mouse and Human {beta}-Cells and Its Targeted Inactivation Impairs Insulin 
Secretion. Endocrinology. 
9. Ueta, C.B., Oskouei, B.N., Olivares, E.L., Pinto, J.R., Correa, M.M., Simovic, G., Simonides, W.S., 
Hare, J.M., and Bianco, A.C. 2012. Absence of myocardial thyroid hormone inactivating 
deiodinase results in restrictive cardiomyopathy in mice. Mol Endocrinol 26:809-818. 
10. Dentice, M., Marsili, A., Ambrosio, R., Guardiola, O., Sibilio, A., Paik, J.H., Minchiotti, G., DePinho, 
R.A., Fenzi, G., Larsen, P.R., et al. 2010. The FoxO3/type 2 deiodinase pathway is required for 
normal mouse myogenesis and muscle regeneration. J Clin Invest 120:4021-4030. 
11. Gereben, B., Zavacki, A.M., Ribich, S., Kim, B.W., Huang, S.A., Simonides, W.S., Zeold, A., and 
Bianco, A.C. 2008. Cellular and molecular basis of deiodinase-regulated thyroid hormone 
signaling. Endocr Rev 29:898-938. 
12. Hernandez, A., Morte, B., Belinchon, M.M., Ceballos, A., and Bernal, J. 2012. Critical role of types 
2 and 3 deiodinases in the negative regulation of gene expression by t3 in the mouse cerebral 
cortex. Endocrinology 153:2919-2928. 
13. Castillo, M., Hall, J.A., Correa-Medina, M., Ueta, C., Won Kang, H., Cohen, D.E., and Bianco, A.C. 
2011. Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes 
obesity with glucose intolerance and liver steatosis only at thermoneutrality. Diabetes 60:1082-
1089. 
14. Feldmann, H.M., Golozoubova, V., Cannon, B., and Nedergaard, J. 2009. UCP1 ablation induces 
obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living 
at thermoneutrality. Cell Metab 9:203-209. 
15. Ueta, C.B., Olivares, E.L., and Bianco, A.C. 2011. Responsiveness to Thyroid Hormone and to 
Ambient Temperature Underlies Differences Between Brown Adipose Tissue and Skeletal 
Muscle Thermogenesis in a Mouse Model of Diet-Induced Obesity. Endocrinology. 
16. Bianco, A.C., Carvalho, S.D., Carvalho, C.R., Rabelo, R., and Moriscot, A.S. 1998. Thyroxine 5'-
deiodination mediates norepinephrine-induced lipogenesis in dispersed brown adipocytes. 
Endocrinology 139:571-578. 
17. Castillo, M., Hall, J.A., Correa-Medina, M., Ueta, C., Kang, H.W., Cohen, D.E., and Bianco, A.C. 
2011. Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes 
obesity with glucose intolerance and liver steatosis only at thermoneutrality. Diabetes 60:1082-
1089. 
18. Bianco, A.C., Kieffer, J.D., and Silva, J.E. 1992. Adenosine 3',5'-monophosphate and thyroid 
hormone control of uncoupling protein messenger ribonucleic acid in freshly dispersed brown 
adipocytes. Endocrinology 130:2625-2633. 
14 
 
19. Bianco, A.C., Sheng, X.Y., and Silva, J.E. 1988. Triiodothyronine amplifies norepinephrine 
stimulation of uncoupling protein gene transcription by a mechanism not requiring protein 
synthesis. J Biol Chem 263:18168-18175. 
20. Branco, M., Ribeiro, M., Negrao, N., and Bianco, A.C. 1999. 3,5,3'-Triiodothyronine actively 
stimulates UCP in brown fat under minimal sympathetic activity. Am J Physiol 276:E179-187. 
21. de Jesus, L.A., Carvalho, S.D., Ribeiro, M.O., Schneider, M., Kim, S.W., Harney, J.W., Larsen, P.R., 
and Bianco, A.C. 2001. The type 2 iodothyronine deiodinase is essential for adaptive 
thermogenesis in brown adipose tissue. J Clin Invest 108:1379-1385. 
22. Christoffolete, M.A., Linardi, C.C., de Jesus, L., Ebina, K.N., Carvalho, S.D., Ribeiro, M.O., Rabelo, 
R., Curcio, C., Martins, L., Kimura, E.T., et al. 2004. Mice with targeted disruption of the Dio2 
gene have cold-induced overexpression of the uncoupling protein 1 gene but fail to increase 
brown adipose tissue lipogenesis and adaptive thermogenesis. Diabetes 53:577-584. 
23. Bianco, A.C., and Silva, J.E. 1988. Cold exposure rapidly induces virtual saturation of brown 
adipose tissue nuclear T3 receptors. Am J Physiol 255:E496-503. 
24. Carvalho, S.D., Kimura, E.T., Bianco, A.C., and Silva, J.E. 1991. Central role of brown adipose 
tissue thyroxine 5'-deiodinase on thyroid hormone-dependent thermogenic response to cold. 
Endocrinology 128:2149-2159. 
25. Crantz, F.R., and Larsen, P.R. 1980. Rapid thyroxine to 3,5,3'-triiodothyronine conversion and 
nuclear 3,5,3'-triiodothyronine binding in rat cerebral cortex and cerebellum. Journal of Clinical 
Investigation 65:935-938. 
26. Grozovsky, R., Ribich, S., Rosene, M.L., Mulcahey, M.A., Huang, S.A., Patti, M.E., Bianco, A.C., 
and Kim, B.W. 2009. Type 2 deiodinase expression is induced by peroxisomal proliferator-
activated receptor-gamma agonists in skeletal myocytes. Endocrinology 150:1976-1983. 
27. Gouveia, C.H., Christoffolete, M.A., Zaitune, C.R., Dora, J.M., Harney, J.W., Maia, A.L., and 
Bianco, A.C. 2005. Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse 
skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation. Endocrinology 
146:195-200. 
28. Guadano-Ferraz, A., Obregon, M.J., St Germain, D.L., and Bernal, J. 1997. The type 2 
iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc Natl 
Acad Sci U S A 94:10391-10396. 
29. Tu, H.M., Kim, S.W., Salvatore, D., Bartha, T., Legradi, G., Larsen, P.R., and Lechan, R.M. 1997. 
Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat 
hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138:3359-
3368. 
30. Coppola, A., Liu, Z.W., Andrews, Z.B., Paradis, E., Roy, M.C., Friedman, J.M., Ricquier, D., Richard, 
D., Horvath, T.L., Gao, X.B., et al. 2007. A central thermogenic-like mechanism in feeding 
regulation: an interplay between arcuate nucleus T3 and UCP2. Cell Metab 5:21-33. 
31. Fekete, C., Gereben, B., Doleschall, M., Harney, J.W., Dora, J.M., Bianco, A.C., Sarkar, S., Liposits, 
Z., Rand, W., Emerson, C., et al. 2004. Lipopolysaccharide induces type 2 iodothyronine 
deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. 
Endocrinology 145:1649-1655. 
32. 1972. Fatty acid metabolism in rats treated with triiodothyronine. Nutr Rev 30:234-236. 
33. Smith, D.C., and Brown, F.C. 1952. The effect of parrot fish thyroid extract on the respiratory 
metabolism of the white rat. Biological Bulletin 102:278-286. 
34. Marsili, A., Aguayo-Mazzucato, C., Chen, T., Kumar, A., Chung, M., Lunsford, E.P., Harney, J.W., 
Van-Tran, T., Gianetti, E., Ramadan, W., et al. 2011. Mice with a targeted deletion of the type 2 
deiodinase are insulin resistant and susceptible to diet induced obesity. PLoS One 6:e20832. 
15 
 
35. Cryer, P.E. 2008. Glucose homeostasis and hypoglycemia. In Williams Textbook of Endocrinology 
Saunders. 1503-1533. 
36. Bianco, A.C., Anderson, G., Forrest, D., Galton, V.A., Gereben, B., Kim, B.W., Kopp, P.A., Liao, 
X.H., Obregon, M.J., Peeters, R.P., et al. 2014. American thyroid association guide to 
investigating thyroid hormone economy and action in rodent and cell models. Thyroid 24:88-
168. 
37. Fonseca, T.L., Correa-Medina, M., Campos, M.P., Wittmann, G., Werneck-de-Castro, J.P., Drigo, 
R.A., Mora-Garzon, M., Ueta, C.B., Caicedo, A., Fekete, C., et al. 2013. Coordination of 
hypothalamic and pituitary T3 production regulates TSH expression. J Clin Invest 123:1492-1500. 
38. Westholm, D.E., Marold, J.D., Viken, K.J., Duerst, A.H., Anderson, G.W., and Rumbley, J.N. 2010. 
Evidence of evolutionary conservation of function between the thyroxine transporter Oatp1c1 
and major facilitator superfamily members. Endocrinology 151:5941-5951. 
39. Zhuo, L., Theis, M., Alvarez-Maya, I., Brenner, M., Willecke, K., and Messing, A. 2001. hGFAP-cre 
transgenic mice for manipulation of glial and neuronal function in vivo. Genesis 31:85-94. 
40. Alkemade, A., Unmehopa, U.A., Wiersinga, W.M., Swaab, D.F., and Fliers, E. 2005. 
Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression 
in the paraventricular nucleus of the human hypothalamus. J Clin Endocrinol Metab 90:323-327. 
41. Lusk, G. 1926. Animal Calorimetry. Analysis of the oxidation of mixtures of carbohydrates and 
fat. The journal of Biology Chemistry 124:41-42. 
42. Medina, M.C., Molina, J., Gadea, Y., Fachado, A., Murillo, M., Simovic, G., Pileggi, A., Hernandez, 
A., Edlund, H., and Bianco, A.C. 2011. The thyroid hormone-inactivating type III deiodinase is 
expressed in mouse and human beta-cells and its targeted inactivation impairs insulin secretion. 
Endocrinology 152:3717-3727. 
43. Christoffolete, M.A., Ribeiro, R., Singru, P., Fekete, C., da Silva, W.S., Gordon, D.F., Huang, S.A., 
Crescenzi, A., Harney, J.W., Ridgway, E.C., et al. 2006. Atypical expression of type 2 
iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin 
feedback mechanism. Endocrinology 147:1735-1743. 
44. Curcio-Morelli, C., Gereben, B., Zavacki, A.M., Kim, B.W., Huang, S., Harney, J.W., Larsen, P.R., 
and Bianco, A.C. 2003. In vivo dimerization of types 1, 2, and 3 iodothyronine selenodeiodinases. 
Endocrinology 144:937-946. 
45. Diano, S., Naftolin, F., Goglia, F., and Horvath, T.L. 1998. Fasting-induced increase in type II 
iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by 
thyroxine in the rat hypothalamus. Endocrinology 139:2879-2884. 
46. Fekete, C., Singru, P.S., Sanchez, E., Sarkar, S., Christoffolete, M.A., Riberio, R.S., Rand, W.M., 
Emerson, C.H., Bianco, A.C., and Lechan, R.M. 2006. Differential effects of central leptin, insulin, 
or glucose administration during fasting on the hypothalamic-pituitary-thyroid axis and feeding-
related neurons in the arcuate nucleus. Endocrinology 147:520-529. 
47. Bianco, A.C., and Silva, J.E. 1987. Optimal response of key enzymes and uncoupling protein to 
cold in BAT depends on local T3 generation. Am J Physiol 253:E255-263. 
48. Carvalho, S.D., Negrao, N., and Bianco, A.C. 1993. Hormonal regulation of malic enzyme and 
glucose-6-phosphate dehydrogenase in brown adipose tissue. Am J Physiol 264:E874-881. 
49. Werneck de Castro, J.P., Fonseca, T.L., Ignacio, D.L., Fernandes, G.W., Baldanza, M.R., Rangel, 
I.F., Balazs, G.B., Miranda, M.F., Andrade, C., Bianco, A.C., et al. 2013. Both skeletal myocytes 
and adipocytes express the type 2 deiodinase within skeletal muscle. In 83rd Annual Meeting of 
the Americam Thyroid Association. San Juan, Porto Rico: American Thyroid Association 69. 
16 
 
50. Lopez, M., Varela, L., Vazquez, M.J., Rodriguez-Cuenca, S., Gonzalez, C.R., Velagapudi, V.R., 
Morgan, D.A., Schoenmakers, E., Agassandian, K., Lage, R., et al. 2010. Hypothalamic AMPK and 
fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med 16:1001-1008. 
51. Morrison, S.F., Madden, C.J., and Tupone, D. 2012. Central control of brown adipose tissue 
thermogenesis. Front Endocrinol (Lausanne) 3. 
52. Mittag, J., Lyons, D.J., Sallstrom, J., Vujovic, M., Dudazy-Gralla, S., Warner, A., Wallis, K., 
Alkemade, A., Nordstrom, K., Monyer, H., et al. 2013. Thyroid hormone is required for 
hypothalamic neurons regulating cardiovascular functions. J Clin Invest 123:509-516. 
53. Bianco, A.C., and Mcaninch, E.A. 2013. The role of thyroid hormone and brown adipose tissue in 
energy homeostasis. The Lancet Diabetes & Endocrinology 1:250-258. 
54. Stakkestad, J.A., and Bremer, J. 1982. The metabolism of fatty acids in hepatocytes isolated from 
triiodothyronine-treated rats. Biochim Biophys Acta 711:90-100. 
55. Stakkestad, J.A., and Bremer, J. 1983. The outer carnitine palmitoyltransferase and regulation of 
fatty acid metabolism in rat liver in different thyroid states. Biochim Biophys Acta 750:244-252. 
56. Ramadan, W., Marsili, A., Huang, S., Larsen, P.R., and Silva, J.E. 2011. Type-2 iodothyronine 
5'deiodinase in skeletal muscle of C57BL/6 mice. I. Identity, subcellular localization, and 
characterization. Endocrinology 152:3082-3092. 
57. Ueta, C.B., Olivares, E.L., and Bianco, A.C. 2011. Responsiveness to thyroid hormone and to 
ambient temperature underlies differences between brown adipose tissue and skeletal muscle 
thermogenesis in a mouse model of diet-induced obesity. Endocrinology 152:3571-3581. 
58. Campos-Barros, A., Hoell, T., Musa, A., Sampaolo, S., Stoltenburg, G., Pinna, G., Eravci, M., 
Meinhold, H., and Baumgartner, A. 1996. Phenolic and tyrosyl ring iodothyronine deiodination 
and thyroid hormone concentrations in the human central nervous system. The Journal of 
Clinical Endocrinology and Metabolism 81:2179-2185. 
59. Cypess, A.M., White, A.P., Vernochet, C., Schulz, T.J., Xue, R., Sass, C.A., Huang, T.L., Roberts-
Toler, C., Weiner, L.S., Sze, C., et al. 2013. Anatomical localization, gene expression profiling and 
functional characterization of adult human neck brown fat. Nat Med 19:635-639. 
60. Virtanen, K.A., Lidell, M.E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, 
J., Savisto, N.J., Enerback, S., et al. 2009. Functional brown adipose tissue in healthy adults. N 
Engl J Med 360:1518-1525. 
 
 
 
  
17 
 
Legend to the figures 
 
Figure 1- Metabolic phenotype of the GLOB-D2KO mouse. GLOB-D2KO and WT controls 
were acclimated to individual metabolic cages in the comprehensive lab animal monitoring sys-
tem (C.L.A.M.S.) for 48 hours before measurements were recorded. A) Oxygen consumption 
(VO2) during 12h light and dark cycles recorded at the second day after acclimatization; B) Same 
as in A, except that what is shown is Respiratory quotient (RQ); C) Contribution of fat oxidation 
to daily energy expenditure during the light cycle; D) Food intake during light and dark cycles of 
animals kept on regular chow diet at room temperature (22oC); E) VO2 during 12h light and dark 
cycles recorded during acute cold (4oC) exposure; F) Same as in E, except that what is shown is 
RQ; G) Food intake during light and dark cycles of animals kept on regular chow diet during the 
period of cold (4oC) exposure; H) VO2 register during chronically (15 days) cold exposed where 
the environment temperature was gradually and progressively decreased every 3-4 days; I) Same 
as in H, except that what is shown is RQ; J) VO2 during 12h light and dark cycles recorded on 
the first day of  48hs of fasting and K) Same as in J, except that what is shown is RQ. Entries are 
mean ± SEM of 3-7 animals. Area under the curve (AUC) was calculated during light and dark 
cycles for each individual animal. Statistical significance is shown in each graph and was set as p 
< 0.05. Student’s t test was used to compare WT and GLOB-D2KO groups within treatment 
conditions. Black horizontal bars denote the dark period of day (12hs). 
 
Figure 2- Metabolic phenotype of the ASTRO-D2KO mouse kept on regular chow diet at 
room temperature (22oC). A) Body weight evolution during 2 months period; B) Body weight 
of the animals right before admission to C.L.A.M.S.; C) Body composition measured by DEXA 
48h before the animals were admit to C.L.A.M.S.; D) VO2 during 12h light and dark cycles; 
ASTRO-D2KO mouse and controls were acclimated to individual metabolic cages in the 
C.L.A.M.S. for 48 hours before measurements were recorded; data shown is the second day after 
acclimatization; E) Same as in D, except that what is shown is RQ; F) Contribution of fat oxida-
tion to daily energy expenditure during the light cycle and G) Food intake of the same animals 
during light and dark cycles. Entries are mean ± SEM of 4-5 animals. Area under the curve 
(AUC) was calculated during light and dark cycles for each individual animal. Statistical signifi-
cance is shown in each graph and was set as p < 0.05. Student’s t test was used to compare con-
trols and ASTRO-D2KO groups within treatment conditions. Black horizontal bars denote the 
dark period of day (12hs).  
 
Figure 3- Metabolic phenotype of the FAT-D2KO mouse kept on regular chow diet. A) 
Body weight evolution during 5 months period of animals kept at room temperature (22oC). The 
FAT-D2KO mouse and controls were acclimated to individual metabolic cages in the 
C.L.A.M.S. for 48 hours before measurements were recorded; B) Body weight of the animals 
right before the animals were admit to C.L.A.M.S.; C) Body composition measured by DEXA 
48h before the animals were admit to C.L.A.M.S.; D) VO2 during 12h light and dark cycles rec-
orded at the second day after acclimatization of animals kept on regular chow diet at room tem-
perature (22oC); E) Same as in D, except that what is shown is RQ; F) Contribution of fat oxida-
tion to daily energy expenditure during the light cycle in the same animals; G) Food intake dur-
ing light and dark cycles in the same animals; H) Blood glucose concentrations at the indicated 
time points after ip glucose injection (2g/kg) in 2-month-old FAT-D2KO and controls animals; 
I)  Blood glucose concentration at the indicated time points before and after ip injection of regu-
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lar human insulin (0.75 U/kg body weight) in 2-month-old FAT-D2KO and control animals; J) 
VO2 during 12h light and dark cycles recorded during chronic (15 days) exposure to 
thermoneutrality (30oC); K) Same as in E, except that what is shown is RQ; L) Food intake dur-
ing light and dark cycles of animals kept at thermoneutrality; M) VO2 during 12h light and dark 
cycles recorded on the first day of  48hs of fasting and N) Same as in J, except that what is 
shown is RQ. Entries are mean ± SEM of 5-12 animals. Area under the curve (AUC) was calcu-
lated during light and dark cycles for each individual animal. Statistical significance is shown in 
each graph and was set as p < 0.05. Student’s t test was used to compare controls and FAT-
D2KO groups within treatment conditions. Black horizontal bars denote the dark period of day 
(12hs). (*, p<0.05; **, p<0.01 and ***, p<0.001 vs. control). 
 
Figure 4- Effect of high-fat diet (HFD) in the FAT-D2KO mice at room temperature and 
thermoneutrality. The FAT-D2KO and controls were fed with HFD for 8 weeks. A) Body 
weight evolution during 8 weeks of treatment of animals kept at room temperature (22oC); B) 
Area under the curve from the BW shown in A was calculated from each individual animal; C) 
Food intake during light and dark cycles in the same animals; D) Body composition measured by 
DEXA in the animals kept at room temperature before (day 1) and after (day 60) HFD; E) Delta 
% of fat measured by DEXA in D, calculated by the difference between days 1 and 60; F) Con-
tribution of fat oxidation to daily energy expenditure during the light cycle in the same animals; 
 G) VO2 during 12h light and dark cycles in the animals kept at room temperature after 8 weeks 
on HFD; The FAT-D2KO mouse and controls were acclimated to individual metabolic cages in 
the C.L.A.M.S. for 48 hours before measurements were recorded; data shown is the second day 
after acclimatization; H) Same as in G, except that what is shown is RQ; I) Body weight evolu-
tion during 8 weeks of treatment of animals kept at thermoneutrality (30oC); J) Area under the 
curve from the BW represented in the figure I, calculated from each individual animal; K) Food 
intake during light and dark cycles in the same animals; L) Body composition measured by 
DEXA in the animals kept at thermoneutrality before (day 1) and after (day 60) HFD; M) Delta 
% of fat measured by DEXA in L, calculated by the difference between days 1 and 60; N) Con-
tribution of fat oxidation to daily energy expenditure during the light cycle in the same animals; 
and O) VO2 during 12h light and dark cycles in the animals kept at thermoneutrality after 8 
weeks on the HFD; P) Same as in O, except that what is shown is RQ; Entries are mean ± SEM 
of 5-6 animals. Statistical significance is shown in each graph and was set as p < 0.05. Student’s 
t test was used to compare controls and FAT-D2KO groups within treatment conditions. Black 
horizontal bars denote the dark period of day (12hs). 
 
 
Figure 5- Metabolic phenotype of the SKM-D2KO mouse kept on regular chow diet and 
HFD at room temperature (22oC). A) Body weight evolution during 2 months period; B) Body 
weight of the animals right before admission to C.L.A.M.S.; C) Body composition measured by 
DEXA 48h before the animals were admit to C.L.A.M.S.; D) VO2 during 12h light and dark cy-
cles; SKM-D2KO mouse and controls were acclimated to individual metabolic cages in the 
C.L.A.M.S. for 48 hours before measurements were recorded; data shown is the second day after 
acclimatization; E) Same as in D, except that what is shown is RQ; F) Contribution of fat oxida-
tion to daily energy expenditure during the light cycle; G) Food intake of the same animals dur-
ing light and dark cycles; H) Body weight evolution during 8 weeks of treatment with HFD in 
animals kept at room temperature (22oC); I) Area under the curve from the BW represented in 
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the figure H, calculated from each individual animal; J) Body composition measured by DEXA 
in the animals kept at room temperature before (day 1) and after (day 60) HFD; K) Delta % of 
fat measured by DEXA in J, calculated by the difference between days 1 and 60; L) VO2 during 
12h light and dark cycles in the animals kept at room temperature after 8 weeks on HFD; The 
SKM-D2KO mouse and controls were acclimated to individual metabolic cages in the 
C.L.A.M.S. for 48 hours before measurements were recorded; data shown is the second day after 
acclimatization and M) Same as in E, except that what is shown is RQ; Entries are mean ± SEM 
of 3-6 animals. Statistical significance is shown in each graph and was set as p < 0.05. Student’s 
t test was used to compare controls and SKM-D2KO groups within treatment conditions. Black 
horizontal bars denote the dark period of day (12hs). 
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Supplemental Figure 1- Energy expenditure (EE) in GLOB-D2KO, ASTRO-D2KO, FAT-D2KO and SKM-D2KO measured under different  
conditions. The KO and WT controls were acclimated to individual metabolic cages in the comprehensive lab animal monitoring system (C.L.A.M.S.) for 
48 hours before measurements were recorded. A) Energy expenditure (EE) during 12h light and dark cycles recorded on the second day after 
acclimatization in the GLOB-D2KO and WT mice at room temperature; B) Same as in A, except measurements were recorded during acute cold (4oC) 
exposure of 24hs duration; C) Same as in A, except measurements were recorded on the first day of a 48hs interval of fasting; D) EE in the ASTRO-
D2KO and controls at room temperature; E) EE in the FAT-D2KO and controls at room temperature; F) Same as in E, except measurements were 
recorded during chronic (15 days) exposure to thermoneutrality (30oC); G) Same as in E, except measurements were recorded on the first day of a 48hs 
interval of fasting; H) Same as in E, except measurements were recorded in the animals kept at room temperature after 8 weeks on HFD; I) Same as in 
H, however the animals were kept at thermoneutrality (30oC); J) EE in the SMK-D2KO and controls at room temperature; L) Same as in J, except 
measurements were recorded in the animals kept at room temperature after 8 weeks on HFD; Entries are mean  SEM. Statistical significance is shown 
in each graph and was set as p < 0.05. Student’s t test was used to compare KO animals and the respective controls.  
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Supplemental figure 2- Characterization of FAT-D2KO mouse. A) Dio2 expression in the BAT of FAT-D2KO mouse and 
Controls (n=5) ; B) D2 activity in sonicate of BAT in  WT, Cre Fabp4, FloxD2 and FAT-D2KO mouse (n=4-6); C) D2 activity in 
sonicate of cortex in control and FAT-D2KO mouse (n=4) and D) Serum TSH, E) T4 and F) T3 levels of control and Fat-D2KO 
mice (n=10-11). Entries are mean  SEM. Statistical significance is shown in each graph and was set as p < 0.05. Student’s t 
test was used to compare controls and FAT-D2KO. (*, p<0.05 and ***, p<0.001 vs. control). 
